Aliivibrio wodanis as a production host: development of genetic tools for expression of cold-active enzymes.
Aliivibrio wodanis
Cold adaptation
Expression host
Heterologous protein production
Marine biotechnology
Psychrophilic enzymes
Journal
Microbial cell factories
ISSN: 1475-2859
Titre abrégé: Microb Cell Fact
Pays: England
ID NLM: 101139812
Informations de publication
Date de publication:
11 Nov 2019
11 Nov 2019
Historique:
received:
03
07
2019
accepted:
31
10
2019
entrez:
13
11
2019
pubmed:
13
11
2019
medline:
9
4
2020
Statut:
epublish
Résumé
Heterologous production of cold-adapted proteins currently represents one of the greatest bottlenecks in the ongoing bioprospecting efforts to find new enzymes from low-temperature environments, such as, the polar oceans that represent essentially untapped resources in this respect. In mesophilic expression hosts such as Escherichia coli, cold-adapted enzymes often form inactive aggregates. Therefore it is necessary to develop new low-temperature expression systems, including identification of new host organisms and complementary genetic tools. Psychrophilic bacteria, including Pseudoalteromonas haloplanktis, Shewanella and Rhodococcus erythropolis have all been explored as candidates for such applications. However to date none of these have found widespread use as efficient expression systems, or are commercially available. In the present work we explored the use of the sub-Arctic bacterium Aliivibrio wodanis as a potential host for heterologous expression of cold-active enzymes. We tested 12 bacterial strains, as well as available vectors, promoters and reporter systems. We used RNA-sequencing to determine the most highly expressed genes and their intrinsic promoters in A. wodanis. In addition we examined a novel 5'-fusion to stimulate protein production and solubility. Finally we tested production of a set of "difficult-to-produce" enzymes originating from various bacteria and one Archaea. Our results show that cold-adapted enzymes can be produced in soluble and active form, even in cases when protein production failed in E. coli due to the formation of inclusion bodies. Moreover, we identified a 60-bp/20-aa fragment from the 5'-end of the AW0309160_00174 gene that stimulates expression of Green Fluorescent Protein and improves production of cold-active enzymes when used as a 5'-fusion. A 25-aa peptide from the same protein enhanced secretion of a 25-aa-sfGFP fusion. Our results indicate the use of A. wodanis and associated genetic tools for low-temperature protein production and indicate that A. wodanis represents an interesting platform for further development of a protein production system that can promote further cold-enzyme discoveries.
Sections du résumé
BACKGROUND
BACKGROUND
Heterologous production of cold-adapted proteins currently represents one of the greatest bottlenecks in the ongoing bioprospecting efforts to find new enzymes from low-temperature environments, such as, the polar oceans that represent essentially untapped resources in this respect. In mesophilic expression hosts such as Escherichia coli, cold-adapted enzymes often form inactive aggregates. Therefore it is necessary to develop new low-temperature expression systems, including identification of new host organisms and complementary genetic tools. Psychrophilic bacteria, including Pseudoalteromonas haloplanktis, Shewanella and Rhodococcus erythropolis have all been explored as candidates for such applications. However to date none of these have found widespread use as efficient expression systems, or are commercially available. In the present work we explored the use of the sub-Arctic bacterium Aliivibrio wodanis as a potential host for heterologous expression of cold-active enzymes.
RESULTS
RESULTS
We tested 12 bacterial strains, as well as available vectors, promoters and reporter systems. We used RNA-sequencing to determine the most highly expressed genes and their intrinsic promoters in A. wodanis. In addition we examined a novel 5'-fusion to stimulate protein production and solubility. Finally we tested production of a set of "difficult-to-produce" enzymes originating from various bacteria and one Archaea. Our results show that cold-adapted enzymes can be produced in soluble and active form, even in cases when protein production failed in E. coli due to the formation of inclusion bodies. Moreover, we identified a 60-bp/20-aa fragment from the 5'-end of the AW0309160_00174 gene that stimulates expression of Green Fluorescent Protein and improves production of cold-active enzymes when used as a 5'-fusion. A 25-aa peptide from the same protein enhanced secretion of a 25-aa-sfGFP fusion.
CONCLUSIONS
CONCLUSIONS
Our results indicate the use of A. wodanis and associated genetic tools for low-temperature protein production and indicate that A. wodanis represents an interesting platform for further development of a protein production system that can promote further cold-enzyme discoveries.
Identifiants
pubmed: 31711487
doi: 10.1186/s12934-019-1247-1
pii: 10.1186/s12934-019-1247-1
pmc: PMC6844050
doi:
Substances chimiques
Bacterial Proteins
0
Enzymes
0
Recombinant Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
197Subventions
Organisme : Norges Forskningsråd
ID : 234541/O30
Organisme : Marine Biotechnology in northern Norway (MABIT)
ID : MABIT-project BS0081
Organisme : Marine Biotechnology in northern Norway (MABIT)
ID : MABIT-project BS0087
Références
Appl Microbiol Biotechnol. 2017 Jan;101(2):725-734
pubmed: 27796433
Microb Cell Fact. 2006 Dec 14;5:40
pubmed: 17169153
Appl Environ Microbiol. 2011 Feb;77(4):1276-83
pubmed: 21183643
Appl Environ Microbiol. 2007 Feb;73(3):906-12
pubmed: 17142370
Appl Environ Microbiol. 2014 Sep;80(17):5530-41
pubmed: 24973072
BMC Genomics. 2015 Jun 10;16:447
pubmed: 26059548
Nat Biotechnol. 2006 Jan;24(1):79-88
pubmed: 16369541
Microb Cell Fact. 2008 Feb 07;7:2
pubmed: 18257924
Mar Biotechnol (NY). 2015 Apr;17(2):130-43
pubmed: 25260971
Protein Expr Purif. 2007 Mar;52(1):210-8
pubmed: 17064934
Protein Expr Purif. 2016 Jul;123:14-8
pubmed: 27033343
Trends Biotechnol. 2000 Mar;18(3):103-7
pubmed: 10675897
J Biosci Bioeng. 2005 Apr;99(4):303-10
pubmed: 16233795
J Mol Biol. 2012 Nov 2;423(4):648-59
pubmed: 22858868
Appl Environ Microbiol. 2007 Aug;73(15):4849-56
pubmed: 17526788
Infect Immun. 2012 May;80(5):1681-9
pubmed: 22371373
PLoS One. 2015 Sep 02;10(9):e0137384
pubmed: 26333173
Environ Microbiol. 2010 Oct;12(10):2658-76
pubmed: 20482592
EMBO Rep. 2014 May;15(5):508-17
pubmed: 24671034
Biomolecules. 2014 Feb 20;4(1):235-51
pubmed: 24970214
Traffic. 2011 May;12(5):543-8
pubmed: 21255213
Nat Rev Microbiol. 2003 Dec;1(3):200-8
pubmed: 15035024
Nat Methods. 2011 Sep 29;8(10):785-6
pubmed: 21959131
J Appl Microbiol. 2013 Sep;115(3):835-47
pubmed: 23725044
Sci Rep. 2017 Aug 1;7(1):6990
pubmed: 28765554
J Bacteriol. 1987 Sep;169(9):4379-83
pubmed: 3040692
J Biotechnol. 2007 Jan 1;127(2):199-210
pubmed: 16959351
Front Microbiol. 2016 Sep 09;7:1408
pubmed: 27667987
Front Microbiol. 2014 Apr 17;5:172
pubmed: 24860555
Microb Cell Fact. 2004 Sep 2;3(1):11
pubmed: 15345063
Nucleic Acids Res. 2004 May 26;32(9):e78
pubmed: 15163763
Curr Opin Biotechnol. 1999 Oct;10(5):411-21
pubmed: 10508629
Methods Mol Biol. 2008;429:v-vii
pubmed: 18700328
Curr Opin Biotechnol. 1996 Apr;7(2):190-7
pubmed: 8791338
BMC Biotechnol. 2011 Oct 12;11:92
pubmed: 21992524
Appl Environ Microbiol. 2013 Nov;79(21):6655-64
pubmed: 23974137
BMC Microbiol. 2015 Mar 24;15:69
pubmed: 25886758
Int J Genomics. 2016;2016:2405954
pubmed: 28053975
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Appl Microbiol Biotechnol. 2014 Jun;98(11):4887-95
pubmed: 24535258
Nat Methods. 2008 Feb;5(2):135-46
pubmed: 18235434
BMC Bioinformatics. 2007 Feb 26;8:64
pubmed: 17324286
Methods Mol Biol. 2012;824:203-18
pubmed: 22160900
Mol Microbiol. 2011 Nov;82(4):894-903
pubmed: 21992506
J Bacteriol. 1996 Mar;178(5):1310-9
pubmed: 8631707
J Biotechnol. 2005 Jan 26;115(2):113-28
pubmed: 15607230
Science. 1977 Dec 9;198(4321):1056-63
pubmed: 412251
Microb Cell Fact. 2010 Sep 21;9:72
pubmed: 20858251
Methods Mol Biol. 2004;267:225-37
pubmed: 15269427
New Microbiol. 2014 Jul;37(3):339-46
pubmed: 25180848
BMC Genomics. 2012 Jan 24;13:37
pubmed: 22272603
Nat Methods. 2013 Jun;10(6):563-9
pubmed: 23644548
Front Bioeng Biotechnol. 2015 Oct 20;3:148
pubmed: 26539430
Methods Enzymol. 2002;358:413-26
pubmed: 12474404